ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Women's Treatment for Trauma and Substance Use Disorders - 1

This study is currently recruiting patients.

Sponsored by: National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute
Information provided by: National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this study is to compare the effectiveness of adding Seeking Safety to standard substance abuse treatment to adding a control condition: Women's Health Education to standard substance abuse treatment.

Condition Treatment or Intervention Phase
Substance-Related Disorders
 Behavior: Behavior Therapy
Phase III

MedlinePlus related topics:  Drug Abuse;   Prescription Drug Abuse

Study Type: Interventional
Study Design: Treatment, Uncontrolled

Official Title: Women's Treatment for Trauma and Substance Use Disorders

Further Study Details: 

Expected Total Enrollment:  420

Study start: April 2003

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Female

Criteria

Inclusion Criteria

- Women with a diagnosis of substance abuse or dependence who also have either full or sub-threshold DSM-IV PTSD.

Exclusion Criteria:

- Women will be excluded from the study who have current psychotic disorders, or a history of active psychosis (past two months); women with a diagnosis of substance abuse or dependence who also have either full or sub-threshold DSM-IV PTSD; and women who have current psychotic disorders, or a history of active psychosis (past two months).


Location and Contact Information

Aimee Campbell, M.S.      (212)523-5198    anoel_campbell@hotmail.com

Connecticut
      LMG Programs, Inc., Stamford,  Connecticut,  06901,  United States; Recruiting
Aimee Campbell, M.S.  212-523-5198    anoel_campbell@hotmail.com 

Florida
      Gateway Community Services, Jacksonville,  Florida,  32224,  United States; Recruiting
Aimee Campbell, M.S.  212-523-5198    anoel_campbell@hotmail.com 

      The Villiage, Miami,  Florida,  33137,  United States; Recruiting
Aimee Campbell, M.S.  212-523-5198    anoel_campbell@hotmail.com 

New York
      Addiction Research & Treatment Corp.-MSUCAS, Brooklyn,  New York,  11238,  United States; Recruiting
Aimee Campbell, M.S.  212-523-5198    anoel_campbell@hotmail.com 

      Addiction Research & Treatment Corp.-RISE, Brooklyn,  New York,  11238,  United States; Recruiting
Aimee Campbell, M.S.  212-523-5198    anoel_campbell@hotmail.com 

Ohio
      Maryhaven, Inc., Columbus,  Ohio,  43207,  United States; No longer recruiting

South Carolina
      Charleston Center, Charleston,  South Carolina,  29403,  United States; Recruiting
Aimee Campbell, M.S.  212-523-5198    anoel_campbell@hotmail.com 

Washington
      Residence XII, Kirkland,  Washington,  98034,  United States; Recruiting
Aimee Campbell, M.S.  212-523-5198    anoel_campbell@hotmail.com 

Study chairs or principal investigators

Denise Hien, Ph.D.,  Principal Investigator,  New York State Psychiatric Institute   

More Information

Study ID Numbers:  NIDA-CTN-0015-1
Record last reviewed:  November 2004
Record first received:  February 19, 2004
ClinicalTrials.gov Identifier:  NCT00078156
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act